Self-renewal of human hematopoietic progenitor cells: Development of novel therapies erythropoietin-resistant anemias
ALL WELCOME
Harvey Lodish is a world-expert in haematopoiesis, particularly focusing on red blood cell development. A major focus is identifying genes and extracellular signals that regulate the self- renewal, proliferation, and differentiation of early erythroid progenitor cells; extracellular signals include activators of the glucocorticoid and PPAR receptors and oxygen. This work has led to the characterization of several molecules, including six that are FDA-approved drugs for other indications that show great promise as therapeutics for bone marrow failure disorders and erythropoietin- resistant anemias. This research involves extensive computational analyses of large datasets of gene expression profiles and chromatin modifications generated from cells at different stages of human and mouse red cell development.
Date: 2 October 2015, 14:30 (Friday, -1st week, Michaelmas 2015)
Venue: Wellcome Trust Centre for Human Genetics, Headington OX3 7BN
Venue Details: Room A
Speaker: Prof. Harvey Lodish (Whitehead Institute)
Organising department: Ludwig Institute for Cancer Research, Oxford Branch
Organisers: Mary Muers (Oxford Ludwig Institute, NDM Experimental Medicine), Alexandra Ward (University of Oxford, Oxford Ludwig Institute, NDM Experimental Medicine)
Organiser contact email address: alexandra.ward@ludwig.ox.ac.uk
Host: Prof Xin Lu (Ludwig Cancer Research, Oxford Branch)
Part of: Ludwig Institute Seminar Series
Booking required?: Not required
Audience: Members of the University only
Editor: Mary Muers